Elizabeth Buck
Förmögenhet: 287 624 $ per 2026-07-31
Förmögenhet: 287 624 $ per 2026-07-31
Elizabeth Buck is the founder of Black Diamond Therapeutics, Inc. since 2014, holding the title of Chief Scientific Officer.
Former job at OSI Pharmaceuticals, Inc. from 2005 to 2013 as Assistant Director-Advanced Preclinical.
Former job at MetaStat, Inc. from 2013 to 2014 as Chief Scientific Officer-Therapeutics.
Education includes an undergraduate degree from the University of New Hampshire and a doctorate from Icahn School of Medicine at Mount Sinai.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-21 | 170 192 ( 0,3 % ) | 287 624 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Grundare | 2014-01-01 |
| Företag | Position | Slut |
|---|---|---|
| METASTAT, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2014-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MetaStat, Inc.
MetaStat, Inc. Electrical ProductsProducer Manufacturing Develops cancer diagnostics technologies | Producer Manufacturing |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån